The role of fibrinogen as a cardiovascular risk factor

Atherosclerosis

Volumn 100, Issue 1, 1993, Pages 1-12

  Ernst, E ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Fibrinogen; Risk factors; Thrombosis

Indexed keywords

FIBRINOGEN;

ATHEROSCLEROSIS; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOSIS;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; FIBRINOGEN; HUMAN; RISK FACTORS; THROMBOSIS;

EID: 0027205171     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(93)90062-Y     Document Type: Review

References (116)

1. How well can we predict coronary heart disease?
2. Plasma fibrinogen — an independent cardiovascular risk factor
3. The normal and morbid biology of fibrinogen
4. Haemostatic function and cardiovascular death: early results of a prospective study
5. Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study
6. Haemostatic factors asociated with ischemic heart disease in men aged 45 to 64 years. The Speedwell Study
7. Some long-term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell collaborative surveys
8. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease
9. Fibrinogen as a risk factor for stroke and myocardial infarction
10. 21-year follow up of CVD and total mortality among men born in 1913
11. Plasma fibrinogen — a major coronary risk factor
12. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study
13. Fibrinogen and risk of cardiovascular disease
14. Fibrinogen — a major cardiovascular risk factor
15. Coagulation factors and the progress of coronary heart disease
16. Predictive value of haemostatic variables in the Procam-Study
17. Fibrinogen: ein koronarer Risikofaktor
18. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population I
19. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population II
20. Hemostatic variables in Japanese and caucasian men
21. An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease
22. Regional differences in fibrinogen levels
23. Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study
24. Lipoproteins and fibrinogen in the general population-results from the MONICA-project Augsburg. Survey 1989/90
25. Plasma fibrinogen and ischemic heart disease risk factors
26. Fibrinogen and cardiovascular risk in the atherosclerosis risk in communities (ARIC) Study
27. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults
28. Relation between extent of coronary artery disease and blood viscosity
29. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis
30. Fibrinogen, factor VII clotting activity and coronary artery disease severity
31. Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease
32. Does blood rheology revert to normal after myocardial infarction?
33. Plasma fibrinogen and thromboemboli after myocardial infarction
34. Haemostatic variables and the outcome of myocardial infarction
35. Plasma viscosity, fibrinogen and haematocrit in the course of unstable angina
36. Influence of platelet size on outcome after myocardial infaction
37. Blood viscosity and fibrinogen concentration following cerebral infarction
38. Blood rheology in patients with transient ischemic attacks
39. Chronic hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke
40. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes
41. Fibrinogen and viscosity, risk factors for stroke survivors
42. Prediction of carotid stenosis progression by lipid and hematologic measurements
43. Haematological stress syndrome in atherosclerosis
44. Clinical haemodynamic, rheological and biochemal findings in 126 patients with intermittent claudication
45. Pilot study of a screening test for peripheral arterial disease in middle aged men, fibrinogen as a possible risk factor
46. Influence of smoking and plasma factors on patency of femoropoplitean vein grafts
47. Update of fibrinogen as a major cardiovascular risk factor: the Framingham study
48. Prognostic value of fibrinogen level in geriatric patients
49. Fibrinogen measurement in various clinical conditions: A comparison of five different methods
50. Seasonal variations in fibrinogen concentrations among elderly people
51. Seasonal fibrinogen fluctuations among elderly people
52. Physiological variations of fibrinogen levels in healthy volunteers
53. Sources of variability in coagulation factor assays
54. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure; prospective observational studies corrected for the regression dilution bias
55. Genetic and cultural inheritance of plasma fibrinogen concentration
56. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations
57. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration
58. The effect of age on the fibrinolytic enzyme system
59. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations
60. Effect of age on different receptors and functions of phagocytic cells
61. Hämorheologische Variablen bei manifesten arteriellen Gefäβerkrankungen
62. Increased plasma fibrinogen, and platelet aggregates in type II hyperlipoproteinaemia
63. Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia
64. Effect of treatment of hyperlipidaemia in haemostatic variables
65. Blood viscosity and hyperlipoproteinemia
66. Cardiovascular risk factors in young snuff-users and cigarette smokers
67. Dose-effect relationship between smoking and blood rheology
68. Smoking and plasma fibrinogen
69. Abstention from chronic cigarette smoking normalizes blood rheology
70. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations
71. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease
72. How soon after quitting smoking does risk of heart attack decline?
73. Fibrinogen and other clotting factors in cardiovascular diseasen
74. Fibrinogen and carboxyhaemoglobin in peripheral arterial disease
75. Plasma viscosity and related variables in healthy cigarette smokers — results from the MONICAproject Augsburg
76. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: role of fibrinogen concentration
77. Koenig, W., Sund, M., Ernst, E., Matrai, A., Keil, U. and Rosenthal, J., Is increased plasma viscosity a risk factor for high blood pressure? Angiology, 40: 153.
78. Elevated fibrinogen and plasminogen activator inhibitor in hypertension are related to metabolic risk factors for cardiovascular disease
79. Diabetes
80. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience
81. Hemostatic measurements in type II diabetic patients with albuminura
82. Hyperfibrinogenemia: a major determinant of vascular complications in diabetes
83. Epidemiology of atheroma and thrombosis
84. Dietary regulation of fibrinolytic factors
85. Eicosapentaenoic acid ethylester as an antithrombotic agent: comparison to an extract of fish oil
86. The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels, a controlled clinical trial in hypertriglyceridemic subjects
87. Dietary determinants of lipoproteins, total cholesterol viscosity, fibrinogen, and blood pressure
88. A randomized controlled trial to investigate the effect of a high fibre diet on blood pressure and plasma fibrinogen
89. Effect of weight reduction on blood viscosity parameters in obese women
90. Fibrinogen and blood rheology in obese children before and after slimming
91. Fibrinogen: a possible link between social class and coronary heart disease
92. Disease and social class: evidence from the Caerphilly and Speedwell studies
93. Cardiovascular risk factors and hemorheology. Physical fitness, stress and obesity
94. Social influences on cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men
95. Effect of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults
96. Influence of power and aerobic exercise training on haemostatic factors after coronary artery surgery
97. The effects of oral contraceptives on fibrinogen
98. The relationship of fetal and infant growth to plasma fibrinogen in adult life
99. Fibrinogen and dental disease — a coronary risk factor
100. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients
101. The effect of fibrinogen concentration and the leukocyte count on intravascular fibrin deposit from soluble fibrin monomer complexes
102. Acute phase reaction, fibrinogen level and thrombus size
103. A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III
104. The possible role of hemorheology in atherothrombogenesis
105. Fibrinogen as a major cardiovascular risk factor in cardiovascular disease
106. Epidemiological characteristics of platelet aggregability
107. Interaction between fibrinogen and cultured endothelial cells
108. Atherosclerosis and the coagulation system
109. Fate of fibrinogen in human arterial intima
110. Inflammation and the onset of myocardial infarction
111. Leukocytes and the risk of ischemic diseases
112. White blood cell count and cardiovascular disease. Insights from the Framingham Study
113. Atherosclerosis Risk in Communities (ARIC) Study
114. Drugs to lower fibrinogen